Abstract
In Alzheimer's disease, the microtubule-associated protein tau dissociates from the neuronal cytoskeleton and aggregates to form cytoplasmic inclusions. Although hyperphosphorylation of tau serine and threonine residues is an established trigger of tau misfunction and aggregation, tau modifications extend to lysine residues as well, raising the possibility that different modification signatures depress or promote aggregation propensity depending on site occupancy. To identify lysine residue modifications associated with normal tau function, soluble tau proteins isolated from four cognitively normal human brains were characterized by MS methods. The major detectable lysine modification was found to be methylation, which appeared in the form of mono- and di-methyl lysine residues distributed among at least 11 sites. Unlike tau phosphorylation sites, the frequency of lysine methylation was highest in the microtubule-binding repeat region that mediates both microtubule binding and homotypic interactions. When purified recombinant human tau was modified in vitro through reductive methylation, its ability to promote tubulin polymerization was retained, whereas its aggregation propensitywas greatly attenuated at both nucleation and extension steps. These data establish lysinemethylation as part of the normal tau post-translational modification signature in human brain, and suggest that it can function in part to protect against pathological tau aggregation.
Original language | English (US) |
---|---|
Pages (from-to) | 77-88 |
Number of pages | 12 |
Journal | Biochemical Journal |
Volume | 462 |
Issue number | 1 |
DOIs | |
State | Published - Jul 15 2014 |
Externally published | Yes |
Keywords
- Aggregation
- Alzheimer's disease
- Methylation
- Microtubule
- Post-translational modification
- Tau protein